It is hard to find anything but good news in the current weekly insider-sentiment data from Vickers Stock Research. Volatility remains the order of the day in the stock market -- but for three consecutive weeks, the data from Vickers has suggested a bottom may be near, or already in. Let's jump right to the numbers. Vickers' NYSE One-Week Sell/Buy Ratio is 1.30 this week, this on a scale where anything below 2.00 is bullish. The ratio has been bullish for the past three weeks. Moving to the Nasdaq, the one-week ratio is 2.40. That is still neutral but closing in on bullish, and the ratio has been strong enough of late to engender nine consecutive weeks of improvement in the broader Nasdaq Eight-Week Sell/Buy Ratio. That reading has improved to 3.28 (neutral) from 5.20 back on March 10. All of the above has Vickers' Total (all exchanges) One-Week Sell/Buy Ratio at a bullish 1.76 and the Total Eight-Week Sell/Buy Ratio close to bullish at 2.63 after nine weeks of improvement. On a sector basis, insider buying exceeded selling in Financials last week, with shares valued at $4.5 million bought versus $3.9 million sold. Buying also outpaced selling in Energy, although volume was light with less than $100,000 shares bought during the period. Selling was the greatest in Consumer Discretionary over the last week, with shares valued at $21 million sold versus just $2 million bought. Selling was also notable in Industrials, Consumer Staples, and Healthcare. This week, analysts at Vickers highlighted insider transactions of interest at HEICO Corp. (NYSE: HEI) and Elevance Health Inc. (NYSE: ELV).

The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

Healthpeak owns a diversified healthcare portfolio of approximately 697 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.

This pick list highlights constituents of the Morningstar US Mid Cap Index that we believe offer investors the best risk-adjusted return prospects. The market capitalization range for U.S. mid-caps typically falls between $1 billion and $8 billion and represents 20% of the total capitalization of the U.S. equity market.